Clindamycin for Acne

Clindamycin phosphate is a lincosamide antibacterial sold as a 1% solution, gel, lotion, foam and medicated pledget. The solution, gel and lotion are indicated for the treatment of acne vulgaris, and the 1% foam carries the same indication with an initial US approval of 1970. It suppresses Cutibacterium acnes on the skin and quiets the inflammation around a blocked follicle. One honest caveat sits in the labeling itself: the exact mechanism by which clindamycin treats acne is described as unknown.

The distinction that decides whether this is your drug is inflammatory versus noninflammatory lesions. Papules and pustules are inflammatory. Blackheads and whiteheads are comedones, which are a plugging problem rather than a bacterial one. In the two double-blind trials behind the original combination gel, adding benzoyl peroxide beat clindamycin gel alone at reducing noninflammatory lesions as well as inflammatory ones. That is exactly where clindamycin on its own runs out of road.

Vehicle changes your routine more than it changes the drug. Solution, lotion and gel go on as a thin film twice a day, while the 1% foam is once daily after washing and drying the skin. The solution is alcohol-based and stings on dry or broken skin. Lotion suits a drier face. Pledgets are single-use swabs that travel well and cost about the same per application.

The cleanest read comes from a phase 2 trial that ran a triple-combination gel against all three of its two-drug versions at once. Among 741 participants, 52.5% reached treatment success at week 12 on clindamycin 1.2% with benzoyl peroxide 3.1% and adapalene 0.15%, against 27.8% to 30.5% on the dyads and 8.1% on vehicle. Every dyad in that trial contained clindamycin or benzoyl peroxide. None of them matched all three together.

Two phase 3 trials repeated the pattern. At week 12, 49.6% and 50.5% of participants on the triple gel achieved treatment success versus 24.9% and 20.5% on vehicle, with inflammatory and noninflammatory lesion reductions ranging from 72.7% to 80.1%. A phase 3 trial in 498 participants pairing clindamycin 1.2% with benzoyl peroxide 3.75% recorded median reductions of 68.4% in inflammatory and 57.9% in noninflammatory lesions, against 35.5% and 32.5% on vehicle.

Read those as group averages from controlled trials rather than a forecast for your face. Individual results vary. Each figure came from once-daily use of a study-supplied product over a fixed 12 weeks, with adherence that real life rarely matches. Note also what every winning arm had in common: not one of them was clindamycin by itself, which is the pattern the rest of this page keeps returning to.

The best fit is red, tender, mild-to-moderate acne where papules and pustules outnumber blackheads, and where you would rather not take an oral antibiotic for months. Adult acne sits inside the studied population rather than being an off-label stretch, though the subgroup evidence for it is thinner than it looks: in post-hoc analyses of a single phase 3 trial, adult women on clindamycin 1.2% with benzoyl peroxide 3.75% reached treatment success at 52.7% against 30.4% on vehicle, a difference the authors report as not statistically significant at p=0.074, and about a third of adolescents reached at least marked improvement by week 2. The authors state the limitation themselves: post-hoc analyses from a single clinical trial with demographic imbalances that could potentially confound the results.

Age limits and exclusions sit in the labeling itself, outside a provider's discretion. The foam is indicated from age 12 and older, as are the fixed-dose clindamycin and benzoyl peroxide gels. One group is excluded outright: topical clindamycin is contraindicated with a history of regional enteritis, ulcerative colitis or antibiotic-associated colitis. Raise any of those before a prescription is written.

The 2024 American Academy of Dermatology acne guidelines make strong recommendations for benzoyl peroxide, topical retinoids, topical antibiotics and oral doxycycline. Clindamycin is on that list. It is not above it. Benzoyl peroxide sits beside it, sells over the counter, costs less per gram and does not select for resistant bacteria the way an antibiotic does. That last property is why benzoyl peroxide turns up inside almost every clindamycin product sold for acne rather than merely beside it.

Head to head, the gap is narrower than the marketing suggests. A Cochrane review of 120 trials found little to no difference between benzoyl peroxide and clindamycin on self-rated acne improvement, at a risk ratio of 0.95 (95% CI 0.68 to 1.34) from a single 240-participant trial rated low-certainty evidence. One small trial, low certainty. Take it as an argument for combining the two rather than a ranking.

For acne along the jaw and chin that flares with your cycle, a topical antibiotic is aimed at the wrong target, and our spironolactone for acne page covers the anti-androgen route the AAD guidelines conditionally recommend. Our tretinoin for acne page covers the comedone side that clindamycin leaves alone, and the two are sold fixed-dose together as a 1.2% clindamycin and 0.025% tretinoin gel.

Clindamycin phosphate solution, lotion and gel are applied as a thin film twice daily to the affected area. The 1% foam is once daily, after washing with a mild soap and letting the skin dry completely, and that label carries a detail worth reading twice: the can is flammable, so keep it away from flame or a cigarette during and right after application.

The combination products are simpler to run. A pea-sized amount of clindamycin 1.2% with benzoyl peroxide 2.5% gel covers the whole face once daily, and the clindamycin, adapalene and benzoyl peroxide gel is a thin layer once daily. One line on the combination labeling sets a boundary most guides skip: use beyond 12 weeks has not been evaluated. Stop at one pea for the whole face, because more product buys irritation rather than speed.

Local reactions dominate the experience: dryness, peeling, burning and itch, all worse with the alcohol-based solution and worse again if you layer a retinoid on the same night. Benzoyl peroxide bleaches fabric on contact, so dark pillowcases and good towels are casualties. Applying at night and letting the skin dry fully first takes most of the sting out. Local irritation commonly eases across the first few weeks as skin adjusts, and a clinician may suggest spacing applications out rather than stopping altogether.

The serious warning is gastrointestinal, and it appears on every topical clindamycin label. Systemic absorption has been demonstrated after topical use, and diarrhea, bloody diarrhea and colitis including pseudomembranous colitis have been reported with both topical and systemic clindamycin. The delayed-onset language on that same labeling is scoped to the other routes: severe colitis has occurred following oral and parenteral administration of clindamycin, with an onset of up to several weeks following cessation of therapy. What the topical labeling reports for topical use is the diarrhea, bloody diarrhea and colitis above, not that delayed onset.

This is rare with a cream on your face.

It is also not theoretical, which is why the labeled instruction is to discontinue when significant diarrhea occurs and to speak to a clinician rather than reaching for an antidiarrheal, since antiperistaltic agents may prolong or worsen the condition. Of everything on this page, that is the one symptom worth raising the same day rather than saving for a scheduled check-in.

There is no over-the-counter clindamycin in the United States, so a prescriber has to write it. Online dermatology visits generally work from photos plus a written history, then route the prescription to a pharmacy or ship the product directly. Whether clindamycin suits your skin is a prescriber's judgment, and nothing on this page is medical advice. A visit typically costs less than an in-person dermatology appointment, with the tradeoff that nobody examines your skin in person before writing the prescription.

Two questions shape a good intake. The first is your history of bowel disease and antibiotic-associated diarrhea, which is a listed contraindication rather than a formality. The second is what else is in the plan. If a service offers to send clindamycin with nothing beside it, that is a reason to ask why before you pay.

This is the single most important thing on the page. A 2025 meta-analysis of 23 studies covering 2,046 Cutibacterium acnes isolates put clindamycin resistance at 22.38% (95% CI 14.69% to 32.56%), and found clindamycin, erythromycin and levofloxacin resistance progressively increasing over time.

Roughly one isolate in five already shrugs the drug off, and the trend line points the wrong way.

That is precisely why fixed-dose combinations exist. Benzoyl peroxide is an oxidizer rather than an antibiotic, so bacteria do not develop resistance to it, and running it alongside clindamycin suppresses the resistant populations that monotherapy would otherwise select for. The 2024 AAD guidelines pair topical antibiotics with other agents and name limiting antibiotic use as a good practice statement. Erythromycin, the other legacy topical antibiotic, fared worse still at 29.20% in the same analysis.

The practical version: if your prescription is clindamycin and nothing else, ask for a combination product or for benzoyl peroxide to run alongside it. The original combination trials showed the pairing beat both single agents on global improvement and inflammatory lesion counts, so this is not a case of trading results for stewardship. You get both at once. Benzoyl peroxide also needs no prescription, which makes it an easy addition even when your clindamycin arrives on its own.

NADAC, the federal benchmark for what pharmacies pay to acquire a drug, is public and dated, which makes it a better anchor than a coupon site. In the file published on 2 September 2026, clindamycin phosphate 1% lotion sits at $0.26105 per mL, 1% foam between $1.91 and $2.30 per gram, pledgets at $0.28403 each, and clindamycin with benzoyl peroxide 1%/5% gel between $0.46606 and $0.73549 per gram. Plain 1% gel needs two listings read together, because that file carries it under two pricing units: twenty listings priced by the gram at $0.13200 and $0.13941, and three priced by the milliliter at $3.48097. Gels are dispensed by weight, so the per-gram listings describe almost every tube you will actually be handed. Translated into what leaves the shelf: a 60 mL bottle of lotion is roughly $16 of acquisition cost, a 45 g tube of the combination gel roughly $21 to $33, and a 30 g tube of plain 1% gel about $4. Retail adds pharmacy markup and a dispensing fee on top, and your copay depends on your plan's formulary tier. Ask which vehicle is being sent before it ships.

Judge an acne service on the whole regimen it prescribes. Ask what is prescribed alongside the clindamycin, because a plan containing benzoyl peroxide or a retinoid matches current guidance and one without it does not. Ask which vehicle you are getting and why, since that single choice moves both tolerability and your out-of-pocket cost by a wide margin. A four-dollar tube of gel and a foam costing twenty times that carry the identical 1% of clindamycin.

Then ask about the calendar. The labeled standard is to stop if there has been no improvement after 6 to 8 weeks or if the condition worsens, so a service that never checks back at that mark is selling refills rather than managing treatment. Confirm someone reviews your bowel history before anything ships, and ask what the plan is at week 12.